What is she best known for?
The fields of study she is best known for:
- Cancer
- Immune system
- Gene
Immunology, Dendritic cell, Immune system, Immunotherapy and Cancer are her primary areas of study.
The study incorporates disciplines such as Melanoma and Cell biology in addition to Immunology.
Her Dendritic cell research incorporates themes from Myeloid, Cancer research, Progenitor cell, CD14 and Vaccination.
Her research integrates issues of Stage, Cervical intraepithelial neoplasia and Lymphoma in her study of Immune system.
Her Immunotherapy research is multidisciplinary, incorporating elements of Cytotoxic T cell, Regulation of gene expression and Transporter.
Her work on Cervical cancer and Cancer immunotherapy as part of general Cancer study is frequently linked to Context, therefore connecting diverse disciplines of science.
Her most cited work include:
- Functional delivery of viral miRNAs via exosomes (1153 citations)
- Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. (505 citations)
- Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial (290 citations)
What are the main themes of her work throughout her whole career to date?
Her primary areas of study are Immunology, Cancer research, Dendritic cell, Immune system and T cell.
As a member of one scientific family, she mostly works in the field of Immunology, focusing on Cytotoxic T cell and, on occasion, Molecular biology.
Her work carried out in the field of Cancer research brings together such families of science as Cervical cancer, Cell, Ex vivo and CD40.
Tanja D. de Gruijl has researched Dendritic cell in several fields, including Cellular differentiation, Myeloid, Myeloid leukemia, Melanoma and Cell biology.
Her Immune system study combines topics in areas such as Bone marrow and Vaccination.
Tanja D. de Gruijl has included themes like Priming, Cytokine and FOXP3 in her T cell study.
She most often published in these fields:
- Immunology (53.12%)
- Cancer research (31.25%)
- Dendritic cell (28.12%)
What were the highlights of her more recent work (between 2018-2021)?
- Cancer research (31.25%)
- Immune system (26.74%)
- Immunotherapy (25.00%)
In recent papers she was focusing on the following fields of study:
Tanja D. de Gruijl spends much of her time researching Cancer research, Immune system, Immunotherapy, T cell and Tumor microenvironment.
Many of her research projects under Cancer research are closely connected to CpG site with CpG site, tying the diverse disciplines of science together.
Her Immune system study is concerned with the field of Immunology as a whole.
Her Immunotherapy research includes themes of Ex vivo, Oncology and Oncolytic virus.
Her T cell study combines topics from a wide range of disciplines, such as Dendritic cell, CD8, Lymph node, Degranulation and Chronic lymphocytic leukemia.
Her Dendritic cell research is multidisciplinary, incorporating perspectives in CTLA-4 and Cell biology.
Between 2018 and 2021, her most popular works were:
- Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19. (43 citations)
- High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy (32 citations)
- Percutaneous Irreversible Electroporation in Locally Advanced and Recurrent Pancreatic Cancer (PANFIRE-2): A Multicenter, Prospective, Single-Arm, Phase II Study. (17 citations)
In her most recent research, the most cited papers focused on:
- Cancer
- Immune system
- Gene
Her scientific interests lie mostly in Cancer research, Antigen, Immunotherapy, Internal medicine and Oncology.
Her work deals with themes such as Cervical cancer, Immune modulation, Immune system and Vaccination, which intersect with Cancer research.
Tanja D. de Gruijl has included themes like Breast cancer, Primary tumor, Melanoma and Lymph in her Immune system study.
Her Antigen study integrates concerns from other disciplines, such as T cell, Antigen-presenting cell and Cell biology.
Cell biology is closely attributed to CD8 in her study.
Her Immunotherapy study incorporates themes from Tumor microenvironment, Ovarian cancer, Radiation therapy and Respiratory virus.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
